SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-18-023427
Filing Date
2018-04-30
Accepted
2018-04-30 07:02:50
Documents
6
Period of Report
2018-06-13
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv491643-def14a.htm DEF 14A 366309
2 GRAPHIC lg_avenue-thera.jpg GRAPHIC 100808
3 GRAPHIC sg_joseph-vazzano.jpg GRAPHIC 19837
4 GRAPHIC sg_lucy-lu.jpg GRAPHIC 18880
5 GRAPHIC tv491643_pc1.jpg GRAPHIC 182752
6 GRAPHIC tv491643_pc2.jpg GRAPHIC 119210
  Complete submission text file 0001144204-18-023427.txt   962637
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEF 14A | Act: 34 | File No.: 001-38114 | Film No.: 18786652
SIC: 2834 Pharmaceutical Preparations